The current study demonstrated that the interaction between TNF pathway–related sTNFR2 CSF levels and TNFRSF1B gene variants contributed to significant differences in AD-associated severity markers such as CSF t-tau and p-tau, MRI measures of interest, and cognitive scores in the ADNI cohort. Here, TNF is linked to Alzheimer disease.